Headquartered in New York, NY·Fiscal year ends December·NYSE: CL·colgatepalmolive.com
About Colgate-Palmolive Company
Colgate-Palmolive Company is a global consumer products company focused on Oral Care, Personal Care, Home Care and Pet Nutrition. It sells products in more than 200 countries and territories.
It reports two businesses:
- **Oral, Personal and Home Care:** organized into North America, Latin America, Europe/Middle East & Africa and Asia Pacific divisions. Products include toothpaste, toothbrushes, skin care, soaps, deodorants and household cleaners.
- **Hill's Pet Nutrition:** therapeutic and wellness pet food under the Hill's Prescription Diet, Hill's Science Diet and Prime100 brands. The company is exiting private label pet food.
Colgate holds global market shares of 41.4% in toothpaste and 33.1% in manual toothbrushes year to date. Emerging markets are a significant growth driver.
Brands include Colgate, Palmolive, Ajax, Axion, Darlie, elmex, EltaMD, Fabuloso, Filorga, hello, Irish Spring, Lady Speed Stick, meridol, PCA SKIN, Protex, Sanex, Softsoap, Sorriso, Soupline, Speed Stick, Suavitel and Tom's of Maine.
The company is executing its 2030 strategy, centered on premium, science-based innovation and increased advertising. It is also running a Strategic Growth and Productivity Program to build flexibility into its cost base. Updated
Colgate-Palmolive cleared $100.99, a fresh one-year high and 1.32% above the peak it set just three days earlier. The move comes a day after Walmart, a customer, disclosed a board appointment.
New 52-week high$98.75+0.8% vs prior high · 2026-02-27
Colgate-Palmolive just printed a 52-week high at $98.75, clearing its late-February peak by 0.82% after eight months of failing to get there. The $100 handle is now within reach for a staples name carrying a $78.5 billion market cap.
Management raised full-year Base Business EPS growth guidance to 5% to 7% and now guides to gross margin expansion, after exceeding expectations for a sixth straight quarter. Latin America net sales growth offset a North America volume decline. The margin upgrade is the part a defensive staples holder cannot ignore.
BSXBoston Scientific Corporation Common Stock (BSX)Partial sell$50K – $100KSep 4
BSXBoston Scientific Corporation Common Stock (BSX)Sell$1K – $15KSep 3
BSXBoston Scientific Corporation Common Stock (BSX)Sell$1K – $15KSep 3
BSXBoston Scientific Corporation Common Stock (BSX)Sell$1K – $15KSep 3
BSXBoston Scientific Corporation Common Stock (BSX)Sell$50K – $100KSep 9
+ 42 more trades in this filing
Made public 29 days after the earliest trade
Hern's 99-trade filing is a near-wholesale exit from energy and industrials, with Devon Energy sold down in three separate blocks of $100,001 to $250,000 and a same-size Exxon trim, while the only buys are Oklahoma municipal bonds and defensive names like Coca-Cola and Chubb. A House Republican rotating out of oil into tax-free paper is worth noting as his own party campaigns on a trading ban.
The Federal Reserve heads into its December 8-9 meeting with the upper bound of the federal funds target range at 4.00%. That level reflects a September 17 increase from 3.75%. Prediction markets…
A strong October quarter sent P&G shares climbing toward a 52-week high, yet oil prices and shrinking margins threaten the rally. Can volume-led growth and a looming Investor Day outrun the commodity…
Both consumer giants beat earnings, yet their margins are moving in opposite directions as oil prices climb and a cautious U.S. shopper holds back. One dividend carries a thin balance sheet buffer,…
When inflation eats into your dividend's buying power, pricing power becomes the one trait separating stocks that keep up from those that quietly fall behind. Three consumer giants are charging more and…
Most retirees watch dividend income pile up in some months and vanish in others, but three stocks with staggered payment schedules can close that gap in a way most income portfolios never…
People buy toothpaste, laundry detergent, diapers, and soda in good economies and bad ones. That steady demand turns into steady cash, and steady cash is what lets a board raise a dividend…
Colgate-Palmolive (NYSE:CL | CL Price Prediction) reports third-quarter results on Friday, Oct. 30. The stock has rose 21.87% year to date. That rally puts a premium price on a business that is…
Both Procter and Gamble and Colgate-Palmolive just raised their dividends and beat earnings estimates, but one of them has a balance sheet vulnerability and a troubled turnaround that retirement investors cannot afford…
Clorox's nearly 6% yield towers over Colgate's modest payout, making it look like a retiree's dream income stock. But a closer look at the balance sheet and cash flow tells a very…
Soda, toothpaste, phone service, electricity, and prescription drugs all share one trait: people keep buying them when the economy turns ugly. Five companies built their businesses around that reality, and the way…
Six dividend stocks, one portfolio, two very different tax outcomes depending on where you hold them. The account you choose today quietly determines how much of every future payout you actually get…
Some of the most boring products in your grocery cart have quietly funded dividend streaks stretching back decades, and five companies selling those exact staples are still raising payouts even as their…
Kimberly-Clark has raised its dividend for over five decades, but a looming $48 billion acquisition and razor-thin cash flow coverage are putting that streak under pressure most income investors haven't noticed yet.
Bond yields are rising fast enough to rattle stocks. The 10-year Treasury yield now stands at 5.24%. When rates rise and valuations wobble, the most reliable income comes from companies that sell…
A gas station attendant and part-time janitor from Vermont quietly accumulated over 95 stocks across five decades, and what his neighbors discovered after his death in 2014 stunned an entire community.
Colgate-Palmolive Company is a global consumer products company focused on Oral Care, Personal Care, Home Care and Pet Nutrition. It sells products in more than 200 countries and territories.
What is the CL stock price target?
24/7 Wall St.'s 12-month price target for CL is $113.08, rated Buy. The Wall Street consensus target is $101.70. CL price prediction →